Skip to site menu Skip to page content

Accelerating PROTAC Programmes to Drug the ‘Undruggable’

By Syngene International

PROteolysis TArgeting Chimeras (PROTACs) have garnered a lot of attention in recent times for their ability to exploit the cell's own degradation machinery to irreversibly degrade target proteins.

In this free white paper, we discuss how Syngene can help you move your PROTAC programmes from hit to lead to the clinic with speed.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content